USPTO serial 79160165
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemical products for use in industry and science namely, difluorosialic acid; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents; chemical preparations for scientific and industrial processes, namely, difluorosialic acid; enzymes for scientific and industrial purposes; biological cell cultures for use in scientific research | SECTION 71 - CANCELLED | — |
| 016 | Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, data packages, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; Printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, production and analysis of glycoproteins, and scientific analysis of antibody-drug conjugates and biotherapeutics; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines, biotherapeutics and antibody-drug conjugates; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; information, advisory and consultancy services relating to the aforesaid | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 27, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 29, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 18, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 27, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 26, 2023 | INPC | INVALIDATION PROCESSED | — |
| May 2, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 2, 2022 | C71T | CANCELLED SECTION 71 | — |
| Feb 16, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 22, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 12, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 26, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 16, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 16, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 16, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 16, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 1, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 1, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 11, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 11, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 11, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 29, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 28, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 24, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 10, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 24, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 24, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 24, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 23, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 17, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |